Nov 30, 2022 / 08:00PM GMT
Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division - VP & Senior Research Analyst
My name is Jess Tassan. I am -- I cover health care tech and distribution at Piper. I'm thrilled to have with me here today Jason Gorevic, CEO of Teladoc; and Mala Murthy, CFO of Teladoc. Thank you both very much for joining.
Jason Nathanial Gorevic - Teladoc Health, Inc. - CEO & Director
Thanks for having us.
Questions and Answers:
Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division - VP & Senior Research AnalystAll right. Great. So we've got 25 minutes for Q&A. I won't direct the questions. You guys can decide where each is best suited. So our overweight thesis on Teladoc is based on your back scale, the integrity of the brand and the potential to drive incremental monetization of each life on the platform. Can you just remind us roughly how many lives touches in 2022 across each product line or maybe in aggregate?
Jason Nathanial Gorevic -